+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

RNA Interference Technology Market Research Report by Therapeutics - United States Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 5123917
  • Report
  • July 2020
  • Region: United States
  • 84 pages
  • 360iResearch™
UP TO OFF
until Dec 31st 2020
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Ionis Pharmaceuticals
  • Merck & Co., Inc.,
  • Quark Pharmaceuticals
  • Silence Therapeutics
  • Thermo Fisher Scientific
  • MORE
The United States RNA Interference Technology Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States RNA Interference Technology Market.

Market Segmentation & Coverage:

This research report categorizes the RNA Interference Technology market to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Therapeutics, the RNA Interference Technology Market studied across Autoimmune Hepatitis, Hepatitis B and C, Neurological Disorders, and Oncology.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the United States RNA Interference Technology Market including Ionis Pharmaceuticals, Merck & Co., Inc.,, Quark Pharmaceuticals, Silence Therapeutics, and Thermo Fisher Scientific.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the RNA Interference Technology Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the United States RNA Interference Technology Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States RNA Interference Technology Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States RNA Interference Technology Market?
4. What is the competitive strategic window for opportunities in the United States RNA Interference Technology Market?
5. What are the technology trends and regulatory frameworks in the United States RNA Interference Technology Market?
6. What are the modes and strategic moves considered suitable for entering the United States RNA Interference Technology Market?
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Ionis Pharmaceuticals
  • Merck & Co., Inc.,
  • Quark Pharmaceuticals
  • Silence Therapeutics
  • Thermo Fisher Scientific
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary
3.1. Market Outlook
3.2. Therapeutics Outlook
3.3. Competitor Outlook

4. Market Overview
4.1. Introduction

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. United States RNA Interference Technology Market, By Therapeutics
6.1. Introduction
6.2. Autoimmune Hepatitis
6.3. Hepatitis B and C
6.4. Neurological Disorders
6.5. Oncology

7. Competitive Strategic Window
7.1. Introduction
7.2. Competitive Strategic Window, by Therapeutics

8. Competitive Landscape
8.1. FPNV Positioning Matrix
8.1.1. Quadrants
8.1.2. Business Strategy
8.1.3. Product Satisfaction
8.2. Market Ranking Analysis
8.3. Market Share Analysis
8.4. Competitive Scenario
8.4.1. Merger & Acquisition
8.4.2. Agreement, Collaboration, & Partnership
8.4.3. New Product Launch & Enhancement
8.4.4. Investment & Funding
8.4.5. Award, Recognition, & Expansion

9. Company Usability Profiles
9.1. Ionis Pharmaceuticals
9.2. Merck & Co., Inc.,
9.3. Quark Pharmaceuticals
9.4. Silence Therapeutics
9.5. Thermo Fisher Scientific

10. Appendix
10.1. Discussion Guide
10.2. Edition Details
10.3. License Details
10.4. Pricing Details

LIST OF FIGURES
FIGURE 1. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET: RESEARCH EXECUTION
FIGURE 3. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2019 VS 2025 (USD MILLION)
FIGURE 5. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET, BY TYPE
FIGURE 6. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 7. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET: MARKET DYNAMICS
FIGURE 8. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2019 VS 2025 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2025 (USD MILLION)
FIGURE 10. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET: FPNV POSITIONING MATRIX
FIGURE 11. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET: MARKET SHARE ANALYSIS

LIST OF TABLES
TABLE 1. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 2. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY AUTOIMMUNE HEPATITIS, 2017-2025 (USD MILLION)
TABLE 3. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY HEPATITIS B AND C, 2017-2025 (USD MILLION)
TABLE 4. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2025 (USD MILLION)
TABLE 5. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2017-2025 (USD MILLION)
TABLE 6. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET: SCORES
TABLE 7. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET: BUSINESS STRATEGY
TABLE 8. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET: PRODUCT SATISFACTION
TABLE 9. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET: RANKING
TABLE 10. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET: MERGER & ACQUISITION
TABLE 11. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 12. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 13. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET: INVESTMENT & FUNDING
TABLE 14. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 15. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET: EDITION DETAILS
TABLE 16. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET: LICENSE DETAILS
TABLE 17. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET: PRICING DETAILS
Note: Product cover images may vary from those shown
3 of 3
  • Ionis Pharmaceuticals
  • Merck & Co., Inc.,
  • Quark Pharmaceuticals
  • Silence Therapeutics
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
Adroll
adroll